23 May 2023

---

Rapid Dose Therapeutics launches QuickStrip dental products in Canada

Tommaso Albonetti

---

Rapid Dose Therapeutics Corp., a Canadian biotechnology company revolutionizing drug delivery through innovation, has launched two unique dental QuickStrip products across the country.

According to a May 10 news release, the QuickStrip technology will initially have two applications in the dental industry:

• LQS, a Lidocaine thin film used professionally as a topical anesthetic application to provide pain free dental treatment and assisting in allowing pain free local anesthetic where injection is required.
• XyliStrip, oral dissolving thin film strip, used for the treatment of dry mouth and xerostomia.

“The initial uptake and interest of the QuickStrip dental products by dentists across the country has been extremely positive, helping to simplify the steps that dentists need to prepare patients for procedures,” said Mark Upsdell, CEO of Rapid Dose Therapeutics, in the news release.

He said that the advent of an oral lidocaine strip adds greatly to a dental clinic’s ability to deliver needle-free dental procedures, resulting in reduced patient anxiety. In addition, "dentists spend a great deal of time managing dry mouth and xerostomia during procedures, which will be reduced significantly with the application of the Xylitol strip.”

About Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company’s flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, which are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient.